Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study

Objective To estimate how much changes in the main risk factors of cardiovascular disease (smoking prevalence, serum cholesterol, and systolic blood pressure) can explain the reduction in coronary heart disease mortality observed among working aged men and women in eastern Finland. Design Population based observational study. Setting Eastern Finland. Participants 34 525 men and women aged 30-59 years who participated in the national FINRISK studies between 1972 and 2012. Interventions Change in main cardiovascular risk factors through population based primary prevention. Main outcome measures Predicted and observed age standardised mortality due to coronary heart disease. Predicted change was estimated with a logistic regression model using risk factor data collected in nine consecutive, population based, risk factor surveys conducted every five years since 1972. Data on observed mortality were obtained from the National Causes of Death Register. Results During the 40 year study period, levels of the three major cardiovascular risk factors decreased except for a small increase in serum cholesterol levels between 2007 and 2012. From years 1969-1972 to 2012, coronary heart disease mortality decreased by 82% (from 643 to 118 deaths per 100 000 people) and 84% (114 to 17) among men and women aged 35-64 years, respectively. During the first 10 years of the study, changes in these three target risk factors contributed to nearly all of the observed mortality reduction. Since the mid-1980s, the observed reduction in mortality has been larger than predicted. In the last 10 years of the study, about two thirds (69% in men and 66% in women) of the reduction could be explained by changes in the three main risk factors, and the remaining third by other factors. Conclusion Reductions in disease burden and mortality due to coronary heart disease can be achieved through the use of population based primary prevention programmes. Secondary prevention among high risk individuals and treatment of acute events of coronary heart disease could confer additional benefit.

[1]  E. Vartiainen,et al.  Time trends in physical activity from 1982 to 2012 in Finland , 2016, Scandinavian journal of medicine & science in sports.

[2]  Katja Borodulin,et al.  Forty-year trends in cardiovascular risk factors in Finland. , 2015, European journal of public health.

[3]  K. Bennett,et al.  Decline in Coronary Mortality in Sweden between 1986 and 2002: Comparing Contributions from Primary and Secondary Prevention , 2015, PloS one.

[4]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[5]  Veikko Salomaa,et al.  Sepelvaltimotaudin kajoavia toimenpiteitä koskevien rekisteritietojen luotettavuus ja kehityssuunnat 1994-2011 , 2014 .

[6]  K. Bennett,et al.  Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008 , 2013, BMC Public Health.

[7]  David M Herrington,et al.  Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. , 2013, Circulation.

[8]  K. Bennett,et al.  Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008 , 2013, Circulation. Cardiovascular quality and outcomes.

[9]  V. Salomaa,et al.  Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future , 2013, Heart.

[10]  MartaPereira,et al.  Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008 , 2013 .

[11]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[12]  P. Kolh,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.

[13]  M. Taskinen,et al.  [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.

[14]  J. Danesh,et al.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.

[15]  T. Laatikainen,et al.  Monitoring diet and diet-related chronic disease risk factors in Finland , 2010, Public Health Nutrition.

[16]  E. Vartiainen,et al.  Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland , 2010, Public Health Nutrition.

[17]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[18]  B. Gersh.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010 .

[19]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, Lancet.

[20]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.

[21]  E. Vartiainen,et al.  The North Karelia Project: From North Karelia to national action: venäjänkielinen laitos , 2009 .

[22]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[23]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[24]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[25]  E. Vartiainen,et al.  Serum cholesterol during 27 years: assessment of systematic error and affecting factors and their role in interpreting population trends. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[26]  T. Laatikainen,et al.  Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population , 2006, European Journal of Clinical Nutrition.

[27]  J. Stockman,et al.  The Mortality of Doctors in Relation to Their Smoking Habits: A Preliminary Report , 2006 .

[28]  V. Salomaa,et al.  Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. , 2005, American journal of epidemiology.

[29]  V. Salomaa,et al.  The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[30]  V. Salomaa,et al.  Total and cause specific mortality among participants and non-participants of population based health surveys: a comprehensive follow up of 54 372 Finnish men and women , 2005, Journal of Epidemiology and Community Health.

[31]  Adrian G Barnett,et al.  Regression to the mean: what it is and how to deal with it. , 2004, International journal of epidemiology.

[32]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice , 2004 .

[33]  E. Vartiainen,et al.  EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Did Finland’s Tobacco Control Act of 1976 have an impact on ever smoking? An examination based on male and female cohort trends , 2004 .

[34]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[35]  Simon Capewell,et al.  Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000 , 2004, Circulation.

[36]  Richard Doll,et al.  The Mortality of Doctors in Relation to Their Smoking Habits , 1954, British medical journal.

[37]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[38]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[39]  M. Marmot,et al.  Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study , 2002, The Lancet.

[40]  Uusitalo Ulla,et al.  Part III. Can we turn back the clock or modify the adverse dynamics? Programme and policy issues , 2002, Public Health Nutrition.

[41]  Uusitalo Ulla,et al.  Influencing public nutrition for non-communicable disease prevention: from community intervention to national programme--experiences from Finland. , 2002, Public health nutrition.

[42]  M. Safar,et al.  Pressure-independent contribution of sodium to large artery structure and function in hypertension. , 2000, Cardiovascular research.

[43]  E. Vartiainen,et al.  Is the Effect of Smoking on the Risk for Coronary Heart Disease Even Stronger than was Previously Thought? , 1999, Journal of cardiovascular risk.

[44]  E. Vartiainen,et al.  Serum cholesterol distribution and coronary heart disease risk: observations and predictions among middle-aged population in eastern Finland. , 1998, Circulation.

[45]  O. Williams.  Total mortality and mortality from heart disease, cancer, and stroke from 1950 to 1987 in 27 countries: Highlights of trends and their interrelationships among causes of death , 1995 .

[46]  E. Vartiainen,et al.  Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland , 1994, BMJ.

[47]  J. Stamler,et al.  The INTERSALT study: background, methods and main results. INTERSALT Co-operative Research Group. , 1989, Journal of human hypertension.

[48]  J. Salonen,et al.  Ten-year results of hypertension care in the community. Follow-up of the North Karelia hypertension control program. , 1988, American journal of epidemiology.

[49]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[50]  D. Hegsted.  Serum-cholesterol response to dietary cholesterol: a re-evaluation. , 1986, The American journal of clinical nutrition.

[51]  J. Salonen,et al.  The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. , 1985, Annual review of public health.

[52]  B. Dawson-Hughes,et al.  Plasma angiotensin II concentration regulates vascular but not adrenal responsiveness to restriction of sodium intake in normal man. , 1981, Clinical science.

[53]  A. Keys.  CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[54]  A. Keys,et al.  Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. , 1965, Metabolism: clinical and experimental.

[55]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.